
Approval is for the 50-µg dosage

Opens a ‘Cold Chain Packaging Center of Excellence’ in Kentucky, while expanding services globally

ConvergeHEALTH Safety intended to automate pharmacovigilance case processing

Separation process expected to be completed in 18-24 months

White House announces official endorsement, paving way for Senate confirmation process

It’s not just innovator pharma companies concerned with the proposed compromise to Medicare price negotiations and inflation-based rebates

Expansion expected to more than double the plant’s footprint

PBM fees and vertical integration are also at the top of the list

CDMO’s expansion of Hopkinton, MA facility will include seven new ISO 7 cGMP suites

Deal expected to boost firm’s offerings via FDS's delivery system services

Boston area facility will focus heavily on cold chain services

Parties expect improved design and selection of eCOAs in decentralized clinical trials

Latest report shows that demand is above pre-crisis numbers, but there are still capacity constraints

Centers for Disease Control and Prevention endorses Pfizer-BioNTech jab, less than two months after firms presented positive study results

Respondents: Pharmacies are still lagging in the compliance requirements that will be in effect in November 2023

ScriptDrop, Adheris Health collaborate to assist patients with their medication regimens

Anticipated capacity of GMP facility is 60 million vials per year

A total of 116.5 million doses for low- and middle-income nations to arrive in Q2 of 2022

Award will support research based on use of real-world evidence in clinical oncology setting

The latest people news happenings over the past month

Additional equipment to be added to the plant next year

Acquisition reportedly increases AI accessibility across life sciences organizations

Development project features additional manufacturing suites, expansion of storage capabilities

Facility features cell storage for CAR-T cell treatments

mRNA jab maker plans to initially produce 50 million Covid vaccine doses per year

Deal provides ten23 with drug product development, biologic manufacturing experience

Agreement prioritizes ways to better distinguish biological manufacturing processes

Italian facilities will supply EU with up to 85 million doses of Covid jab

Biologics manufacturer to construct new C> facility to support expansion